EHC241220C60000
- 20.20
- 0.000.00%
Encompass Health Newsroom
Mizuho Securities Maintains Encompass Health(EHC.US) With Buy Rating, Announces Target Price $110
Truist Financial Maintains Encompass Health(EHC.US) With Buy Rating, Announces Target Price $116
RBC Capital Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $110
Encompass Health Is Maintained at Outperform by RBC Capital
A Quick Look at Today's Ratings for Encompass Health(EHC.US), With a Forecast Between $110 to $116
A Quick Look at Today's Ratings for Encompass Health(EHC.US), With a Forecast Between $102 to $116
Encompass Health Price Target Raised to $117.00/Share From $115.00 by Keybanc
Encompass Health Is Maintained at Overweight by Keybanc
Mizuho Securities Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $105
Truist Financial Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $108
Encompass Health Price Target Announced at $115.00/Share by Keybanc
Encompass Health Analyst Ratings
Encompass Health Initiated With an Overweight at KeyBanc
RBC Capital Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $105
Encompass Health Is Maintained at Buy by UBS
Encompass Health Price Target Raised to $110.00/Share From $100.00 by UBS
Encompass Health Analyst Ratings
UBS Maintains Encompass Health(EHC.US) With Buy Rating, Raises Target Price to $110
Encompass Health Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Encompass Health (EHC) and Ardent Health Partners, Inc. (ARDT)